Positron (New York) Overview
- Year Founded
-
1983
- Status
-
Public
- Employees
-
10
- Stock Symbol
-
POSC
- Investments
-
5
- Share Price
-
$1.65
- (As of Tuesday Closing)
Positron (New York) General Information
Description
Positron Corp is a medical technology company engaged in the co-development, manufacture, and sale of PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. By combining proprietary PET and PET-CT systems with comprehensive clinical and technical support, flexible financing, & a focus on operational efficiency, Positron makes advance diagnostic imaging more accessible & sustainable for hospitals, outpatient centers, & physician practices. The company focused on advancing positron emission tomography imaging through the development, manufacture, & commercialization of PET & PET-computed tomography imaging systems.
Contact Information
Website
www.positron.comCorporate Office
- 1777 Maryland Avenue
- Niagara Falls, NY 14305
- United States
Corporate Office
- 1777 Maryland Avenue
- Niagara Falls, NY 14305
- United States
Positron (New York) Timeline
Positron (New York) Stock Performance
As of 17-Nov-2026, Positron (New York)’s stock price is $1.65. Its current market cap is $54.2M with 32.8M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.65 | $1.65 | $1.27 - $2.74 | $54.2M | 32.8M | 16.8K | -$0.32 |
Positron (New York) Financials Summary
As of 30-Sep-2026, Positron (New York) has a trailing 12-month revenue of $436K.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2014 31-Dec-2014 |
|---|---|---|---|---|
| EV | 59,982 | 52,445 | 26,189 | 8,222 |
| Revenue | 436 | 461 | 588 | 1,466 |
| EBITDA | (9,908) | (10,459) | (2,167) | (609) |
| Net Income | (10,072) | (10,603) | (2,379) | (2,584) |
| Total Assets | 3,657 | 4,000 | 1,801 | 1,869 |
| Total Debt | 3,087 | 1,947 | 2,057 | 470 |
Positron (New York) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Positron (New York) Comparisons
Industry
Financing
Details
Positron (New York) Competitors (15)
One of Positron (New York)’s 15 competitors is GE HealthCare Technologies, a Corporation company based in Chicago, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GE HealthCare Technologies | Corporation | Chicago, IL | ||||
| Agendia | Venture Capital-Backed | Irvine, CA | ||||
| DESTINA | Formerly VC-backed | Granada, Spain | ||||
| Arthrex | Private Equity-Backed | Naples, FL | ||||
| Asuragen | Formerly VC-backed | Austin, TX |
Positron (New York) Patents
Positron (New York) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20120305789-A1 | Method and device for quality control of radiopharmaceuticals | Inactive | 01-Jun-2011 | ||
| US-D648360-S1 | Actuator bridge | Inactive | 28-Oct-2010 |
Positron (New York) Signals
Positron (New York) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Positron (New York) Investments & Acquisitions (5)
Positron (New York)’s most recent deal was a Merger/Acquisition with Manhattan Isotope Technology for . The deal was made on 17-Jan-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Manhattan Isotope Technology | 17-Jan-2012 | Merger/Acquisition | Biotechnology | ||
| Dose Shield | 11-Jun-2008 | Merger/Acquisition | Other Devices and Supplies | ||
| Imaging Pet Technologies | 26-Jan-2007 | Merger/Acquisition | Monitoring Equipment | ||
| IS2 Medical Systems | 06-Jun-2006 | Merger/Acquisition | Diagnostic Equipment | ||
| Imaging Pet Technologies | 28-Dec-2005 | Joint Venture | Monitoring Equipment |
Positron (New York) ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Positron (New York) FAQs
-
When was Positron (New York) founded?
Positron (New York) was founded in 1983.
-
Where is Positron (New York) headquartered?
Positron (New York) is headquartered in Niagara Falls, NY.
-
What is the size of Positron (New York)?
Positron (New York) has 10 total employees.
-
What industry is Positron (New York) in?
Positron (New York)’s primary industry is Diagnostic Equipment.
-
Is Positron (New York) a private or public company?
Positron (New York) is a Public company.
-
What is Positron (New York)’s stock symbol?
The ticker symbol for Positron (New York) is POSC.
-
What is the current stock price of Positron (New York)?
As of 17-Nov-2026 the stock price of Positron (New York) is $1.65.
-
What is the current market cap of Positron (New York)?
The current market capitalization of Positron (New York) is $54.2M.
-
What is Positron (New York)’s current revenue?
The trailing twelve month revenue for Positron (New York) is $436K.
-
Who are Positron (New York)’s competitors?
GE HealthCare Technologies, Agendia, DESTINA, Arthrex, and Asuragen are some of the 15 competitors of Positron (New York).
-
What is Positron (New York)’s annual earnings per share (EPS)?
Positron (New York)’s EPS for 12 months was -$0.32.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process